Bevacizumab for treatment of choroidal neovascularization secondary to candida chorioretinitis
Crossref DOI link: https://doi.org/10.1007/s10792-017-0502-x
Published Online: 2017-03-30
Published Print: 2018-04
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Makragiannis, Georgios
Vahdani, Kaveh
CarreƱo, Ester http://orcid.org/0000-0002-0055-9547
Lee, Richard W. J.
Dick, Andrew D.
Ross, Adam H.
Funding for this research was provided by:
National Institute for Health Research
License valid from 2017-03-30